Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cytokines in tumor therapy].

A Lindemann1, W Oster, F Herrmann

  • 1Abteilung für Hämatologie, Universität Mainz.

Arzneimittel-Forschung
|March 1, 1988
PubMed
Summary

Recombinant cytokines, like interferon alfa, show promise in cancer therapy by modulating tumor-host interactions. Hematopoietic growth factors offer a promising approach for immune stimulation and recovery after cancer treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the DNA Damage Response in OSCC with TP53 Mutations.

Journal of dental research·2018
Same author

Nanoparticel labelling of stem cell populations in head and neck cancer.

Journal of stem cells & regenerative medicine·2014
Same author

The dental and orthodontic instruments.

Zahnarztliche Welt·2010
Same author

Design and validation of a partial-genome microarray for transcriptional profiling of the Bradyrhizobium japonicum symbiotic gene region.

Molecular genetics and genomics : MGG·2005
Same author

Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation.

Bone marrow transplantation·2004
Same author

Directed biosynthesis of new enniatins.

The Journal of antibiotics·2002

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Context:

  • Cytotoxic chemotherapy lacks specificity, impacting all rapidly proliferating tissues.
  • Recombinant cytokines offer targeted modulation of tumor-host interactions.
  • Interferon alfa demonstrates significant efficacy in hairy cell leukemia treatment.

Purpose:

  • To explore the therapeutic potential of recombinant cytokines in cancer treatment.
  • To evaluate the efficacy of various cytokines, including interferon alfa, tumor necrosis factor alfa, and interleukin-2 activated killer cells.
  • To assess the role of hematopoietic growth factors in cancer therapy and supportive care.

Summary:

  • Recombinant cytokines, such as interferon alfa, offer a novel dimension in cancer treatment by modulating tumor-host interactions.
  • While some cytokines like tumor necrosis factor alfa and IL-2 activated killer cells show limited efficacy, interferon alfa has proven effective in specific leukemias.
  • Hematopoietic growth factors present a promising strategy for stimulating host defense and aiding recovery from chemotherapy and transplantation.

Impact:

  • Recombinant cytokines represent a new frontier in cancer therapy, offering more specific mechanisms than traditional chemotherapy.
  • Hematopoietic growth factors are poised to become crucial in managing tumor diseases by supporting the immune system and facilitating recovery.
  • This research highlights the potential of cytokine-based therapies and supportive growth factors in improving cancer patient outcomes.

Related Experiment Videos